Europe Cellulite Treatment Market Forecast 2023-2032

Europe Cellulite Treatment Market Forecast 2023-2032

KEY FINDINGS

The Europe cellulite treatment market is expected to grow with a CAGR of 9.47% during the forecasting period of 2023-2032. The regional market’s growth is fueled by the surge in the occurrence of obesity, coupled with the rise in the aging population, the increasing adoption of advanced technologies as well as the launch of new products, and the growing inclination towards minimally invasive and non-invasive procedures.

MARKET INSIGHTS

The Europe cellulite treatment market growth assessment entails the evaluation of France, Italy, Belgium, Germany, the United Kingdom, Poland, and Rest of Europe. The high fashion, as well as aesthetic consciousness in France, is anticipated to fuel the demand for cellulite treatments over the upcoming years. Moreover, the surging availability of plastic surgeons as well as the growing beauty consciousness in the country, is set to further fuel the number of cellulite treatment procedures, thus contributing to market growth.

According to the data issued by the Organization for Economic Cooperation and Development (OECD), while around 1 in 10 people in France are obese, nearly 40% are overweight. Additionally, as per World Bank data, approximately 21% of the country’s population was aged 65 years and over. Since excess weight leads to cellulite and obesity increases with age, the surging incidence of obesity is further expected to drive the need for cellulite treatments in France. As a result, these factors are projected to play an essential role in propelling market growth in Europe during the forecast period.

COMPETITIVE INSIGHTS

Major companies operating in the market are Zimmer MedizinSysteme, Inceler Medikal Co Ltd, Sinclair Pharma, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
2.3. Scope Of Study
2.4. Crisis Scenario Analysis
2.5. Major Market Findings
2.5.1. Rising Beauty Consciousness
2.5.2. Growing Preference Towards Non-invasive Procedures
2.5.3. Rapid Technological Advancements To Promote Market Growth
2.5.4. Rapidly Changing Lifestyles Leading To Obesity
3. Market Dynamics
3.1. Key Drivers
3.1.1. Growing Demand For Aesthetic And Cosmetic Procedures
3.1.2. Rising Cases Of Obesity
3.1.3. Rapidly Booming Medical Tourism Industry
3.2. Key Restraints
3.2.1. High Cost Of Advanced Cellulite Treatment
3.2.2. Side Effects Post-treatment
3.2.3. Lack Of Awareness
4. Key Analytics
4.1. Parent Market Analysis
4.2. Key Technology Trends
4.3. Porter’s Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Growth Prospect Mapping
4.5. Market Maturity Analysis
4.6. Market Concentration Analysis
4.7. Value Chain Analysis
4.7.1. Research And Development
4.7.2. Product Development
4.7.3. Marketing And Distribution
4.7.4. Post-sales Monitoring
4.8. Key Buying Criteria
4.8.1. Cost
4.8.2. Brand Reputation
4.8.3. Usability
5. Market By Procedure
5.1. Non-invasive
5.2. Minimally Invasive
5.3. Topical
6. Market By Type
6.1. Soft Cellulite
6.2. Hard Cellulite
6.3. Edematous Cellulite
7. Market By End-user
7.1. Hospitals
7.2. Clinics And Beauty Centers
7.3. Other End-users
8. Geographical Analysis
8.1. Europe
8.1.1. Market Size & Estimates
8.1.2. Europe Cellulite Treatment Market Drivers
8.1.3. Europe Cellulite Treatment Market Challenges
8.1.4. Europe Cellulite Treatment Market Regulatory Framework
8.1.5. Key Players In Europe Cellulite Treatment Market
8.1.6. Country Analysis
8.1.6.1. United Kingdom
8.1.6.1.1. United Kingdom Cellulite Treatment Market Size & Opportunities
8.1.6.2. Germany
8.1.6.2.1. Germany Cellulite Treatment Market Size & Opportunities
8.1.6.3. France
8.1.6.3.1. France Cellulite Treatment Market Size & Opportunities
8.1.6.4. Italy
8.1.6.4.1. Italy Cellulite Treatment Market Size & Opportunities
8.1.6.5. Belgium
8.1.6.5.1. Belgium Cellulite Treatment Market Size & Opportunities
8.1.6.6. Poland
8.1.6.6.1. Poland Cellulite Treatment Market Size & Opportunities
8.1.6.7. Rest Of Europe
8.1.6.7.1. Rest Of Europe Cellulite Treatment Market Size & Opportunities
9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Acquisitions
9.1.2. Product Launches & Developments
9.1.3. Partnerships & Agreements
9.1.4. Expansions & Divestitures
9.2. Company Profiles
9.2.1. Abbvie Inc
9.2.1.1. Company Overview
9.2.1.2. Financial Analysis
9.2.1.3. Products / Services List
9.2.1.4. Strengths & Challenges
9.2.2. Alma Lasers
9.2.2.1. Company Overview
9.2.2.2. Products / Services List
9.2.3. Bausch Health Companies Inc.
9.2.3.1. Company Overview
9.2.3.2. Financial Analysis
9.2.3.3. Products / Services List
9.2.3.4. Strengths & Challenges
9.2.4. Candela Corporation
9.2.4.1. Company Overview
9.2.4.2. Products / Services List
9.2.4.3. Strengths & Challenges
9.2.5. Cutera Inc
9.2.5.1. Company Overview
9.2.5.2. Financial Analysis
9.2.5.3. Products / Services List
9.2.5.4. Strengths & Challenges
9.2.6. Cynosure Llc
9.2.6.1. Company Overview
9.2.6.2. Products / Services List
9.2.6.3. Strengths & Challenges
9.2.7. Endo International Plc
9.2.7.1. Company Overview
9.2.7.2. Financial Analysis
9.2.7.3. Products / Services List
9.2.7.4. Strengths & Challenges
9.2.8. Galderma Sa
9.2.8.1. Company Overview
9.2.8.2. Products / Services List
9.2.8.3. Strengths & Challenges
9.2.9. Inceler Medikal Co Ltd
9.2.9.1. Company Overview
9.2.9.2. Products / Services List
9.2.9.3. Strengths & Challenges
9.2.10. Johnson & Johnson
9.2.10.1. Company Overview
9.2.10.2. Financial Analysis
9.2.10.3. Products / Services List
9.2.10.4. Strengths & Challenges
9.2.11. Merz Pharma Gmbh & Co Kgaa
9.2.11.1. Company Overview
9.2.11.2. Products / Services List
9.2.11.3. Strengths & Challenges
9.2.12. Nubway Co Ltd
9.2.12.1. Company Overview
9.2.12.2. Products / Services List
9.2.13. Sientra Inc
9.2.13.1. Company Overview
9.2.13.2. Financial Analysis
9.2.13.3. Products / Services List
9.2.13.4. Strengths & Challenges
9.2.14. Sinclair Pharma
9.2.14.1. Company Overview
9.2.14.2. Products / Services List
9.2.15. Zimmer Medizinsysteme
9.2.15.1. Company Overview
9.2.15.2. Products / Services List
9.2.15.3. Strengths & Challenges

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings